G42 Healthcare collaborates with AWS to transform healthcare data

Amazon Web Services (AWS), an Amazon.com company, has announced the launch of its newest addition to AWS’s growing AWS for Health suite of purpose-built services. Amazon Omics enables large-scale analysis and collaborative research without requiring customers to worry about provisioning the underlying infrastructure.

Users can devote more time to science and health improvement with Amazon Omics, knowing that the underlying service supports their security and compliance posture. Amazon Omics automates bioinformatics workflow provisioning and scaling, allowing bioinformaticians, researchers, and scientists to run analysis pipelines at production scale and devote more time to research and innovation.

Abu Dhabi-based G42 Healthcare is already using Amazon Omics to power its omics workflows. Ashish Koshi, CEO at G42 Healthcare said: “Amazon Omics allows G42 to accelerate a competitive and deployable end-to-end service with globally leading data governance. We’re able to leverage the extensive omics data management and bioinformatics solutions hosted globally on AWS, at our customers’ fingertips. Our collaboration with AWS is much more than data – it’s about value.”

Furthermore, users can use multimodal analysis to combine genomic, biological, and population health data to generate insights and provide more personalized care. For example, they can use Amazon SageMaker to train ML models to help researchers predict whether individuals are predisposed to certain diseases. Users can also combine an individual’s genome data with their medical history from Amazon HealthLake to provide better diagnosis and personalized treatment plans. Amazon Omics is also HIPAA-compliant.